Akiko Okamoto,1,2 Masaki Yamasaki,3 Isao Yokota,4 Maiko Mori,3 Megumi Matsuda,3 Yosuke Yamaguchi,3 Shunsuke Yamakita,3 Hiroshi Ueno,2 Teiji Sawa,3 Tetsuya Taguchi,1 Toyoshi Hosokawa,2 Fumimasa Amaya3 1Department of Endocrinological and Breast Surgery, 2Department of Pain Management and Palliative Care Medicine, 3Department of Anesthesiology, 4Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan Purpose: Predictive value and accuracy of the acute pain trajectory were compared with those of pain intensity at 1 day after the surgery for pain prevalence at 6 months after the surgery.Materials and methods: Female patients scheduled for breast cancer surgery were eligible for this...
Acute pain after breast surgery decreases the quality of life of cancer survivors. Previous studies ...
Persistent pain after surgery in breast cancer has a significant impact on the patient’s surviv...
Funding: The Ketorolac in Breast Cancer trial has been supported by the Anticancer Fund, the Belgian...
Purpose: Persistent pain after breast cancer surgery is a well-recognized problem, with moderate to ...
BACKGROUND Persistent pain extending beyond 6 months after breast cancer surgery when adjuvant thera...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
The aim of this study was to identify clinical risk factors for unfavorable pain trajectories after ...
The aim of this study was to identify clinical risk factors for unfavorable pain trajectories after ...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Purpose: This study investigated (1) the prevalence of pain following breast cancer treatment includ...
UnlabelledStudy purposes were to determine the prevalence of persistent pain in the breast; characte...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Acute pain after breast surgery decreases the quality of life of cancer survivors. Previous studies ...
Persistent pain after surgery in breast cancer has a significant impact on the patient’s surviv...
Funding: The Ketorolac in Breast Cancer trial has been supported by the Anticancer Fund, the Belgian...
Purpose: Persistent pain after breast cancer surgery is a well-recognized problem, with moderate to ...
BACKGROUND Persistent pain extending beyond 6 months after breast cancer surgery when adjuvant thera...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
Background and aims: Persistent post-surgical pain (PPSP) is significant issue following breast canc...
The aim of this study was to identify clinical risk factors for unfavorable pain trajectories after ...
The aim of this study was to identify clinical risk factors for unfavorable pain trajectories after ...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Purpose: This study investigated (1) the prevalence of pain following breast cancer treatment includ...
UnlabelledStudy purposes were to determine the prevalence of persistent pain in the breast; characte...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Background:Few epidemiological studies have prospectively investigated preoperative and surgical ris...
Acute pain after breast surgery decreases the quality of life of cancer survivors. Previous studies ...
Persistent pain after surgery in breast cancer has a significant impact on the patient’s surviv...
Funding: The Ketorolac in Breast Cancer trial has been supported by the Anticancer Fund, the Belgian...